Finally, Clark and co-workers reported that detectable plasma levels of methylated GSTP1 were associated with a poorer response to chemotherapy in castrate-resistant PCa and a poorer survival [60]. This evidence concerns the gene GSTP1 and posterior cortical atrophy.